A detailed history of Cibc Private Wealth Group, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,400 shares of CDXS stock, worth $14,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,400
Previous 3,400 -0.0%
Holding current value
$14,722
Previous $10,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.59 - $4.65 $8,806 - $15,810
3,400 New
3,400 $11,000
Q3 2018

Nov 14, 2018

SELL
$13.35 - $19.1 $6,675 - $9,550
-500 Closed
0 $0
Q1 2018

May 17, 2018

BUY
$8.0 - $12.8 $4,000 - $6,400
500 New
500 $6,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $284M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.